Development of inclusion complex of brinzolamide with hydroxypropyl-β- cyclodextrin

Carbohydrate Polymers

Volumn 98, Issue 1, 2013, Pages 638-643

  Zhang, Ying ^a   Ren, Ke ^b   He, Zhiyao ^a   Li, Huili ^a   Chen, Tong ^c   Lei, Yi ^a   Xia, Shan ^d   He, Gu ^a   Xie, Yongmei ^a   Zheng, Yu ^a   Song, Xiangrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d CHENGDU NORMAL UNIVERSITY   (China)

Author keywords

Brinzolamide; Cornea permeability; Glaucoma; Hydroxypropyl cyclodextrin; Inclusion complex; Intraocular pressure

Indexed keywords

CARBONIC ANHYDRASE; CYCLODEXTRINS; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY;

BRINZOLAMIDE; DIFFERENTIAL SCANNING CALORIMETERS; GLAUCOMA; INCLUSION COMPLEX; INTRA OCULAR PRESSURE; OPTIC NEUROPATHIES; SOLVENT EVAPORATION METHOD; THERAPEUTIC EFFECTS;

OPHTHALMOLOGY;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; BRINZOLAMIDE; SOLVENT; SULFONAMIDE; THIAZINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; CORNEA; CORNEA PERMEABILITY; DRUG EFFECT; GLAUCOMA; HYDROXYPROPYL-Β-CYCLODEXTRIN; INCLUSION COMPLEX; INTRAOCULAR PRESSURE; METABOLISM; PERMEABILITY; PH; RABBIT; SOLUBILITY; VOLATILIZATION;

BRINZOLAMIDE; CORNEA PERMEABILITY; GLAUCOMA; HYDROXYPROPYL-Β-CYCLODEXTRIN; INCLUSION COMPLEX; INTRAOCULAR PRESSURE;

ANIMALS; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CORNEA; HYDROGEN-ION CONCENTRATION; INTRAOCULAR PRESSURE; PERMEABILITY; RABBITS; SOLUBILITY; SOLVENTS; SULFONAMIDES; THIAZINES; VOLATILIZATION;

EID: 84885165020     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.06.052     Document Type: Article

References (14)

1. Bozkir, A., Denli, Z. F., & Basaran, B. (2012). Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery. Acta Poloniae Pharmaceutica, 69(4), 719-724.
2. DeSantis, L. (2000). Preclinical overview of brinzolamide. Survey of Ophthalmology, 44(s2), s119-s129.
3. Goskonda, V. R., Hill, R. A., Khan, M. A., & Reddy, I. K. (2000). Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: A comparative study. Pharmaceutical Development and Technology, 5(3), 409-416. (Pubitemid 30602849)
4. Heijl, A., Leske, M. C., Bengtsson, B., Hyman, L., & Hussein, M. (2002). Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology, 120(10), 1268-1279. (Pubitemid 36105431)
5. Hu, L., Zhang, H., Song, W., Gu, D., & Hu, Q. (2012). Investigation of inclusion complex of cilnidipine with hydroxypropyl-beta-cyclodextrin. Carbohydrate Polymers, 90(4), 1719-1724.
6. Iester, M. (2008). Brinzolamide. Expert Opinion on Pharmacotherapy, 9(4), 653-662. (Pubitemid 351425392)
7. Jansook, P., Stefansson, E., Thorsteinsdottir, M., Sigurdsson, B. B., Kristjansdottir, S. S., Bas, J. F., et al. (2010). Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), 208-214.
8. Li, S., Luo, X., He, J., Xie, Y., Li, J., Wang, N., et al. (2012). Development of intravenous formulation of a novel multikinase inhibitor for treating cancer based on 2- hydroxypropyl-cyclodextrin inclusion complex. Advanced Science Letters, 17, 320-324.
9. Loftssona, T., & Jarvinen, T. (1999). Cyclodextrins in ophthalmic drug delivery. Advanced Drug Delivery Reviews, 36(1), 59-79. (Pubitemid 29074477)
10. Palma, S. D., Tartara, L. I., Quinteros, D., Allemandi, D. A., Longhi, M. R., & Granero, G. E. (2009). An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration. Journal of Controlled Release, 138(1), 24-31.
11. Quigley, H. A. (2011). Glaucoma. Lancet, 377(9774), 1367-1377.
12. Siesky, B., Harris, A., Cantor, L. B., Kagemann, L., Weitzman, Y., McCranor, L., et al. (2008). A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma. British Journal of Ophthalmology, 92(4), 500-504. (Pubitemid 351497977)
13. Vega, E., Gamisans, F., Garcia, M. L., Chauvet, A., Lacoulonche, F., & Egea, M. A. (2008). PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions. Journal of Pharmaceutical Sciences, 97(12), 5306-5317.
14. Zhao, C., Wang, Y., Su, Y., Zhang, H., Ding, L., Yan, X., et al. (2011). Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities. International Journal of Pharmaceutics, 421(2), 301-309.